Cala Trio therapy is a groundbreaking treatment designed to temporarily and effectively reduce your hand tremor. It is the first and only non-invasive therapy that directly targets the source of the tremor by gently stimulating the wrist nerves with electricity (neuromodulation), and targeting the root cause of essential tremor.1

The Cala Trio device is FDA-cleared, safe, effective, and individually calibrated to each patient's unique brain signal pattern.1–3

How it works

1Cala Trio therapy measures your specific tremor.

2Gentle stimulation is sent to the median and radial nerves, traveling to the brain.

3The stimulation interrupts the tremor in the ventral intermediate nucleus of the thalamus part of the brain.

Results illustrating before and after Cala Trio therapy session.4

This image is an actual patient test (Archimedes Spiral Task) before and after a 40-minute treatment with the Cala Trio therapy.

arrow
During in-clinical evaluation after twice daily at home use:1
71%

71% of patients-reported improvement in holding a cup of tea in Activities of Daily Living.1

Cala Band Cala Band
Cala Band Cala Band
68%

68% of patients who self-rated as having “Severe or Moderate” difficulty in their activities of daily living self-rated as “Mild” or better at the end of the study. Patients reported using Bain-Finley Activities of Daily Living [BF-ADL]).1

94 minutes

64% of patients reported persistent relief for an average of 94 minutes (standard deviation = 138; median = 60).1

Contraindications: Cala Trio therapy should NOT be used by patients with an implanted electrical medical device, those with suspected or diagnosed epilepsy or other seizure disorders, or used on the treated wrist with diseased skin (e.g., swollen, infected, inflamed areas, or open wounds), or by patients who are or may be pregnant.

Review all safety information before using the Cala Trio therapy, CalaTrio.com/Safety.3

Clinical Research
Summary
Affordable Access

Cala Health is committed to ensuring all patients have access to Cala Trio therapy and insurance coverage for the device. Our Cala Customer Care specialists offer the following assistance to facilitate patient access to therapy:

  • Benefit verification, prior authorization processing.
  • Collects medical necessity documentation working directly with healthcare provider.
  • Appeals in the event coverage is denied at no cost to the patient.
  • Offers financial assistance for patients who qualify.

Cala Health invites patients to participate in our no-obligation, no upfront cost evaluation period to determine if the Cala Trio therapy is right for you.* If the patient decides that the Cala Trio therapy is not right for them, they simply return the device to Cala Health before the end of the 60-day evaluation period and will not be financially responsible for any costs.

*Patient agreement and must be in place.

Cala Trio Therapy Survey
Affordable Access

Cala Health is committed to ensuring all patients have access to Cala Trio therapy and insurance coverage for the device. Our Cala Customer Care specialists offer the following assistance to facilitate patient access to therapy:

  • Benefit verification, prior authorization processing.
  • Collects medical necessity documentation working directly with healthcare provider.
  • Appeals in the event coverage is denied at no cost to the patient.
  • Offers financial assistance for patients who qualify.

Cala Health invites patients to participate in our no-obligation, no upfront cost evaluation period to determine if the Cala Trio therapy is right for you.* If the patient decides that the Cala Trio therapy is not right for them, they simply return the device to Cala Health before the end of the 60-day evaluation period and will not be financially responsible for any costs.

*Patient agreement and must be in place.

Cala Trio Therapy Survey
Testimonials
  1. Isaacson SH, et al. Tremor and Other Hyperkinetic Movements. 2020;10:29. doi:10.5334/tohm.59. As measured by Cala device following three months of repeated home use in 205 patients with essential tremor who completed the study. Many participants were also taking medication for their tremor and it was difficult to assess the effect of the device compared to medication.
  2. Food and Drug Administration (FDA) has cleared the Cala Trio K203288.
  3. Safety information. Most common reported side effects include mild to moderate skin irritation including electrical stimulation burns, redness and/or itching where the device touched the skin. For comprehensive safety information, visit CalaTrio.com/Safety.
  4. Lin PT, Ross EK, Chidester P, et al. (2018). Noninvasive neuromodulation in essential tremor demonstrates relief in a sham-controlled pilot trial. Mov Disorder, John Wiley and Sons Inc.; p. 1182–1183. Mov Disord. 2018 Jul; 33(7): 1182–1183.
stay in touch

Thanks for the interest!

We will be answering you shortly

Keep browsing